FDA Inspection
VitalantVitalant – FDA Inspection, Apr 18, 2017
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on April 18, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Mark W. Babbitt (Issuing Officer)
View Company Profile
ID · 28a89513-b90a-4ba4-a459-011efca7d337
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1009225
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 22, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 2, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 8, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 31, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1278748 - 2025-07-22
- FDA Inspection 1211673 - 2023-08-02
- FDA Inspection 1101239 - 2019-07-16
- FDA Inspection 899398 - 2014-10-08
- FDA Inspection 805484 - 2012-10-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.